# Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

> **NCT00855595** · PHASE4 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 207 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** Azelaic acid (Finacea, BAY39-6251)
- **DRUG:** Metronidazole (Metrogel)
- **DRUG:** Doxycycline (Oracea)

## Key facts

- **NCT ID:** NCT00855595
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855595, "Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00855595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*